3
Announcements
Trials
Browse
Landscape
Status
Completed
7
Recruiting
4
Unknown
3
Withdrawn
1
Active not recruiting
1
Sponsor Class
OTHER
2
OTHER_GOV
1
Study Type
Observational
3
Sponsor
Cancer Type
CNS
3
Thoracic
1
Sarcoma
1
Conditions
Brain Neoplasms
2
Stroke
1
Radiation Injuries
1
Parkinson Disease
1
Medulloblastoma
1
Infratentorial Neoplasms
1
Cognitive Dysfunction
1
Interventions
Temozolomide
66
Radiotherapy
52
Carboplatin
25
Bevacizumab
21
Cisplatin
19
Radiosurgery
18
Vincristine
17
Etoposide
17
Cyclophosphamide
17
Surgical Procedures, Operative
13
Magnetic Resonance Spectroscopy
13
Chemotherapy, Adjuvant
11
Melphalan
10
Lomustine
10
Drug Therapy
10
Filgrastim
9
Erlotinib Hydrochloride
9
apatinib
8
Pemetrexed
8
3-Iodobenzylguanidine
8
anlotinib
7
Radiation
7
Peripheral Blood Stem Cell Transplantation
7
Methotrexate
7
Thiotepa
6
Isotretinoin
6
Irinotecan
6
Ifosfamide
6
Doxorubicin
6
Carmustine
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Unknown
×
Neuropsychological Tests
×
CNS
×
Clear all
NCT05791006
2023-03-30
NEUROFIN
Istituto Auxologico Italiano
Unknown
99 enrolled
NCT04292353
2021-05-05
WP-12
University of Aarhus
Unknown
67 enrolled
NCT04174820
2020-11-19
CervIRM
University Hospital, Angers
Unknown
145 enrolled